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INTRODUCTION
Insulin stimulates glucose transport in adipose tissue and
muscle through the translocation of a glucose transporter
isoform, GLUT4, from an intracellular site to the cell surface
(Bell et al., 1993; James et al., 1994). Fundamental to this
response is the efficient intracellular sequestration of GLUT4.
In order to understand the mechanism by which GLUT4 is
excluded from the cell surface in the absence of insulin, and
how insulin stimulates the translocation of GLUT4, it is
essential to define the nature of the intracellular compart-
ment(s) in which it resides. GLUT4 has been localised in
adipocytes and muscle by electron microscopy (Slot et al.,
1991a,b; Rodnick et al., 1992). Although the transporter is
found in endosomes and in the trans-Golgi reticulum (TGR)
the majority is located in a tubulo-vesicular (T-V) compart-
ment. In an effort to characterise this compartment a number
of laboratories have immuno-isolated GLUT4-containing
vesicles and studied their constituent proteins. The majority of
the proteins found to date are of endosomal origin. These
include the mannose 6-phosphate receptor (Tanner and
Lienhard, 1989), the transferrin receptor (TfR) (Tanner and
Lienhard, 1989; Hanpeter and James, 1995), transferrin
(Hanpeter and James, 1995) and cellubrevin (Volchuk et al.,
1995; Martin et al., 1996). However, one of the major con-
stituents, at least as determined by protein staining, is a 165
kDa protein which has been characterised as an aminopepti-
dase (Kandror and Pilch, 1994; Mastick et al., 1994; Kandror
et al., 1994; Keller et al., 1995). This protein is unique
compared to most other co-inhabitants of GLUT4-containing
vesicles because it has a very similar distribution and insulin
regulation to GLUT4 (Ross et al., 1996).
Results obtained previously using an endosomal ablation
technique, in conjunction with immuno-electron microscopy
(immuno-EM) on vesicles isolated from adipocytes, has
enabled us to resolve two separate GLUT4 compartments in
adipocytes (Livingstone et al., 1996; Martin et al., 1996). One
compartment comprised approximately 40% of intracellular
GLUT4 and contained several endosomal markers including
the mannose 6-phosphate receptor, the TfR and cellubrevin.
The second compartment, comprising the remaining GLUT4,
was devoid of endosomal markers but contained VAMP2, a
synaptobrevin isoform also found in small synaptic vesicles
(Schiavo et al., 1992; Südhof et al., 1993). In the present study
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The aminopeptidase vp165 is one of the major polypeptides
enriched in GLUT4-containing vesicles immuno-isolated
from adipocytes. In the present study we have confirmed
and quantified the high degree of colocalisation between
GLUT4 and vp165 using double label immuno-electron
microscopy on vesicles isolated from adipocytes and heart.
The percentage of vp165-containing vesicles that also
contained GLUT4 was 91%, 76%, and 86% in rat
adipocytes, 3T3-L1 adipocytes, and rat heart, respectively.
Internalisation of a transferrin/HRP (Tf/HRP) conjugate
by 3T3-L1 adipocytes, followed by diaminobenzidine
treatment in intact cells, resulted in ablation of only 41%
and 45% of GLUT4 and vp165, respectively, whereas
endosomal markers are almost quantitatively ablated.
Using immuno-electron microscopy on cryosections it was
determined that in atrial cardiomyocytes GLUT4 and
vp165 colocalised in a population of tubulo-vesicular (T-V)
elements that were often found close to the plasma
membrane. Double label immunocytochemistry indicated a
high degree of overlap in these T-V elements between
GLUT4 and vp165. However, in atrial cardiomyocytes a
large proportion of GLUT4 was also present in secretory
granules containing atrial natriuretic factor (ANF). In
contrast, very little vp165 was detected in ANF granules.
These data indicate that GLUT4 and vp165 are colocalised
in an intracellular, post-endocytic, tubulo-vesicular com-
partment in adipocytes and cardiomyocytes suggesting that
both proteins are sorted in a similar manner in these cells.
However, GLUT4 but not vp165 is additionally localised in
the regulated secretory pathway in atrial cardiomyocytes.
Key words: Insulin action, Protein targeting
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we have used a variety of morphological techniques, as well as
the endosomal ablation technique, to compare the distribution
of vp165 and GLUT4 in adipocytes and cardiomyocytes. The
results suggest that these two proteins have very similar, but




HRP-conjugated goat anti-rabbit IgG and enhanced chemi-lumin-
escence (ECL) detection kits were from Amersham (Aylesbury, UK).
All tissue culture reagents were from Gibco BRL, with the exception
of foetal calf serum which was from CSL (Commonwealth Serum
Laboratories, Parkville, Australia). Poly(vinylidene difluoride)
blotting membranes were from Millipore (Massachusetts, USA). BCA
protein assay kits were from Pierce (Rockford, Illinois, USA). Cy3-
conjugated goat anti-rabbit IgG was obtained from Jackson
ImmunoResearch Labs (West Grove, PA, USA). Protein A-gold was
prepared as previously described (Roth et al., 1978; Slot and Geuze,
1985). All other chemicals were of high quality commercial grades.
Antibodies
Antisera raised against a synthetic peptide corresponding to the C-
terminal 12 amino acids of GLUT4 (James et al., 1989) has been
described previously. Antibodies raised against a fusion protein con-
sisting of the cytoplasmic N-terminal domain (amino acids 2-109) of
vp165 and glutathione S-transferase, and affinity-purified using the
fusion protein coupled to a glutathione-Sepharose column, have also
been described previously (Keller et al., 1995). Antiserum raised
against the N terminus of pro-ANF was a gift from Dr Gaétan Thibault
(ICRM, Montreal, Canada).
Preparation of cells and tissues
3T3-L1 fibroblasts (ATCC) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% new-born calf
serum, 2 mM L-glutamine, 100 units/l penicillin and 100 mg/l strep-
tomycin at 37°C in an atmosphere of 5% CO2. Cells were passaged
at sub-confluency. Confluent cells were differentiated into adipocytes
as described (Frost and Lane, 1985). Cells were used at day 8 post-
differentiation. To establish basal conditions prior to use, 3T3-L1 cells
were incubated for 2 hours in serum-free DMEM. 
Primary adipocytes were prepared from the epididymal fat pads of
male Wistar rats by the collagenase digestion technique (Simpson et
al., 1983). Following isolation, the adipocytes were incubated in
modified KRP (12.5 mM Hepes, 120 mM NaCl, 6 mM KCl, 1.2 mM
MgSO4, 1 mM CaCl2, 1 mM sodium phosphate, 2 mM sodium
pyruvate, 2% BSA, pH 7.4) for 30 minutes to establish basal con-
ditions.
Total membrane fractions were prepared from rat tissues, primary
rat adipocytes, 3T3-L1 adipocytes and 3T3-L1 fibroblasts as described
previously (Martin et al., 1996). Subcellular fractionation of 3T3-L1
adipocytes was performed as described by Piper et al. (1991).
Immunolabelling of cryosections and isolated vesicles
Male Wistar rats were fasted overnight with free access to water.
Perfusion fixation, using 4% paraformaldehyde in 0.1 M phosphate
buffer, pH 7.4, for 5 minutes, was performed as previously described
(Slot et al., 1991a) on animals anaesthetised with pentobarbitone.
Hearts were then collected and fixation was prolonged by immersing
the tissue samples in fixative for a further 1-2 hours at room temper-
ature. Fixed hearts were stored in 2% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.4, at 4°C.
Ultracryomicrotomy was performed by a slight modification of the
Tokuyasu technique (Tokuyasu, 1980). The atria were dissected from
the hearts. Atrial blocks (~1 mm3) were rinsed briefly in PBS, then
incubated in 2.3 M sucrose for 2 hours at room temperature. All
blocks were then mounted on specimen holders and frozen in liquid
nitrogen. For fluorescence microscopy semi-thin sections (~350 nm)
were cut at −90°C, and for electron microscopy ultra-thin sections
(~55 nm) were cut at −120°C, using a Leica Ultracut S/FCS cryomi-
crotome (Leica Instruments Pty Ltd, North Ryde, Australia) equipped
with a Diatome anti-static device (Diatome, Biel, Switzerland), and a
diamond knife designed for ultracryotomy (Drukker, Cuyck, The
Netherlands). Sections were picked up and thawed on the surface of
a drop of 1.15 M sucrose/1% methylcellulose (Liou et al., 1996).
Semi-thin sections were then transferred to poly-L lysine coated glass
slides, and ultra-thin sections transferred to Formvar carbon-coated
copper grids.
Semi-thin sections were immunolabelled for fluorescence
microscopy using Cy3-conjugated goat anti-rabbit IgG as a fluores-
cent marker. Prior to labelling of ultra-thin tissue sections the
sucrose/methylcellulose was diffused from the surface of the grids by
incubation on a plate of solid 2% gelatin in 0.1 M phosphate buffer,
pH 7.4, containing 0.05% sodium azide, until the gelatin had liquefied.
Immunolabelling was then performed as described previously (Martin
et al., 1996). Grids were dried and viewed using a Jeol 1010 trans-
mission electron microscope. 
Heart from rats fed ad libitum was finely chopped in 2× 20 mM
Hepes, 250 mM sucrose, 1 mM EDTA, pH 7.4 (HES buffer), con-
taining 10 µg/ml leupeptin, 10 µg/ml aprotinin, 250 µM PMSF, and
homogenised thoroughly using a Polytron homogeniser. Vesicles were
prepared from the heart homogenate, and from 3T3-L1 adipocyte and
rat adipocyte homogenates as described previously (Martin et al.,
1996). Fixed membrane vesicles were stored at 4°C. Immunolabelling
of vesicles was performed as described previously (Martin et al.,
1996).
Endosome ablation
The Tf/HRP was prepared using the carbodiimide method of Kishida
et al. (1975). The use of the Tf/HRP conjugate for ablation of
endosomes in 3T3-L1 adipocytes has been described in detail in
previous studies (Livingstone et al., 1996; Martin et al., 1996). Before
use, the conjugate was iron-loaded as described by West et al. (1994).
Basal 3T3-L1 adipocytes were incubated with the Tf/HRP for the
times and at the temperatures indicated in the Results. Cells were then
transferred to ice, and the diaminobenzidine (DAB) cytochemistry
reactions performed in the absence or presence of H2O2. Cells were
washed once with PBS containing 5 mg/ml BSA and three times with
ice-cold HES buffer, prior to subcellular fractionation.
SDS-PAGE and western blotting
SDS-PAGE was performed by the method of Laemmli (1970) using
7.5% or 10% polyacrylamide resolving gels. Proteins resolved by
SDS-PAGE were electrophoretically transferred to poly(vinylidene
difluoride) by the method of Towbin et al. (1979). Membranes were
incubated with rabbit polyclonal antibodies specific for either GLUT-
4 (1 µg/ml) or vp165 (1 µg/ml), and immunoreactive proteins were
detected using either 125I-goat anti-rabbit IgG followed by autoradi-
ography or HRP-conjugated goat anti-rabbit IgG (1:10,000) followed
by ECL, respectively. For the quantitation of ECL signals different
protein loadings were used on the gel for each sample to ensure that
the response was linear. 
RESULTS
Colocalisation of vp165 and GLUT4 in isolated
vesicles
Previous biochemical studies have shown that there is a high
degree of colocalisation between vp165 and GLUT4 in
S. Martin and others
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adipocytes (Mastick et al., 1994; Kandror and Pilch, 1994;
Keller et al., 1995; Ross et al., 1996). We have recently used
immuno-EM on whole mount vesicle preparations isolated
from adipocytes to compare the distribution of GLUT4 with
other markers in individual vesicles (Martin et al., 1996). Using
this technique it is possible to both analyse the labelling, and
detect variations in protein content across a uniform popula-
tion of vesicles. Furthermore, it has been our experience that a
much higher labelling efficiency can be achieved using isolated
vesicles than using cryosections.
Vesicles were prepared from 3T3-L1 adipocytes, primary rat
adipocytes (Fig. 1) and heart, and labelled for GLUT4 and
vp165. The results from the analysis of labelling in adipocytes
are shown in Table 1. As determined using single-labelling, the
total labelled vesicle pool size was very similar for vp165 and
GLUT4. Also, the amount of labelling for both antibodies was
similar as illustrated by comparing the average number of gold
particles per vesicle. This latter value is presented ± s.d. in
order to demonstrate the range in the number of gold particles
labelling individual vesicles. Using double-labelling the co-
localisation between GLUT4 and vp165 was also determined
(Table 1). In vesicles isolated from rat adipocytes there was a
high degree of colocalisation, with 90.6% of the vp165-con-
taining vesicles co-labelling for GLUT4, and 71.7% of the
GLUT4-containing vesicles co-labelling with vp165 antibodies
(Table 1 and Fig. 1). In 3T3-L1 adipocytes, 76.5% of the
vp165-containing vesicles contained GLUT4 and 71.8% of the
GLUT4-containing vesicles contained vp165. Thus, there is a
high degree of colocalisation between GLUT4 and vp165 in
adipocytes. Variations in the degree of colocalisation in rat
adipocytes and 3T3-L1 adipocytes may be due to differences
in the amounts of vp165 and GLUT4 expressed in these cells. 
Vesicles were also prepared from total rat heart to compare
the overlap in labelling in this tissue with that observed in
adipocytes (Table 1). In these vesicles (which are predomi-
nantly derived from ventricular cardiomyocytes) vp165 and
GLUT4 labelled 14% and 15% of the total vesicle pool, respec-
tively. The average number of gold particles per vesicle was 10
for GLUT4 and 3 for vp165. There was again a very high
degree of colocalisation between vp165 and GLUT4 in heart
Fig. 1. Immuno-electron microscopy
for vp165 and GLUT4 in rat
adipocyte vesicles. Intracellular
vesicles were prepared from non-
stimulated rat adipocytes as
described by Martin et al. (1996).
Vesicles were absorbed to Formvar
carbon-coated copper grids and
double-labelled using antibodies
specific for vp165 followed by
Protein A-gold (10 nm), and GLUT4
followed by Protein A-gold (5 nm).
Similar labelling was observed in
vesicles isolated from 3T3-L1
adipocytes and rat heart (results not
shown). Bar, 100 nm.
Table 1. Analysis of vesicle labelling and colocalisation of vp165 and GLUT4, determined by immuno-EM
% Colocalisation
Total vesicles Labelling average* vp165 vesicles
labelled (%) (gold particles/vesicle) containing GLUT4 vesicles
vp165 GLUT4 vp165 GLUT4 GLUT4 containing vp165
3T3-L1 adipocytes 16.9±2.5 18.1±2.8 4.0±3.8 2.7±2.6 76.5±5.6 71.8±7.0
Rat adipocytes 20.0±4.2 22.9±1.8 2.5±1.6 7.4±5.9 90.6±4.6 71.7±4.5
Rat heart 14 15 3 10 86 80
Intracellular vesicles were prepared from rat adipocytes, rat heart and 3T3-L1 adipocytes as described in Materials and Methods. Vesicles were single-labelled
using antibodies specific for vp165 and GLUT4, followed by 10 nm Protein A-gold. For each protein in each cell type the percentage of the total vesicles labelled
and the average number of gold particles per vesicle were determined. The degree of colocalisation between vp165 and GLUT4 was determined using double-
labelling, as a function of the total population of either vp165 vesicles, or of GLUT4 vesicles, that contained the other marker. For rat heart a single preparation of
vesicles was used. For rat adipocytes and 3T3-L1 adipocytes data represents the mean ± s.e.m. except * mean ± s.d., of 3 separate experiments. In each
experiment 200-300 individual vesicles were quantified.
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vesicles with 86% of the vp165-containing vesicles also con-
taining GLUT4 and 80% of the GLUT4-containing vesicles
co-labelling for vp165. Thus, these results were very similar to
those obtained using vesicles from adipocytes.
In rat adipocyte vesicles the distribution of the number of
gold particles per vesicle, summarised in Table 1, was analysed
further (Fig. 2). The results in Fig. 2 demonstrate that most of
the GLUT4 labelling is in vesicles that contain between 4-10
GLUT4 gold particles, with a peak at 6 gold. However, there
are also vesicles which contain as few as 1-2 gold particles,
and those that contain in excess of 20 gold particles. In an
attempt to analyse the distribution of vp165 with respect to the
distribution of GLUT4, the percentage of the total vp165
labelling present in the GLUT4 vesicles was also calculated.
The distribution of vp165 mirrors that of GLUT4, however, the
curve is offset slightly in favour of more vp165 in vesicles con-
taining 6-10 GLUT4 gold particles, with a peak at 8 gold.
Although the labelling was much lower for vp165 a similar
result was obtained with the vp165 vesicles (inset, Fig. 2). 
Endosome ablation
Studies of the intracellular distribution of GLUT4 following
ablation of early endosomes has shown that GLUT4 is present
in at least two biochemically distinct compartments. While one
contains endosomal marker proteins such as the TfR and cel-
lubrevin, the second compartment is largely devoid of these
proteins (Livingstone et al., 1996; Martin et al., 1996). One aim
of the present study was to determine whether vp165 is colo-
calised in this second compartment with GLUT4.
3T3-L1 adipocytes were incubated at 37°C for either 1 hour
or 3 hours with the Tf/HRP conjugate prior to treatment with
DAB ± peroxide. It has previously been shown that cells treated
with DAB in the absence of peroxide are not effected by
ablation (Livingstone et al., 1996) and therefore, this treatment
was used as a control in all experiments. Two different time
points were chosen to ensure that the TfR pathway was
saturated with the Tf/HRP conjugate. In these experiments,
ablation of the TfR was found to be >95% following a 3 hour
uptake at 37°C (results not shown). The treated cells were frac-
tionated and the amount of GLUT4 and vp165 in the intracel-
lular membrane fraction was determined by immunoblotting
(Fig. 3). The immunoblots were quantified by densitometry
(Table 2). The amount of GLUT4 remaining in the intracellu-
lar membranes following ablation was 61% and 59% at 1 hour
and 3 hours, respectively, and the amount of vp165 was 58%
and 55% at 1 hour and 3 hours, respectively (Table 2).
S. Martin and others
Fig. 2. Analysis of rat adipocyte vesicle double-labelling. Intracellular vesicles were isolated from rat adipocytes and double-labelled for
GLUT4 and vp165. The number of GLUT4 gold particles and vp165 gold particles labelling each vesicle was determined and analysed. On the
main graph the x-axis corresponds to the number of GLUT4 gold particles per individual vesicle. The y-axis corresponds to either the
percentage of the total number of GLUT4 vesicles containing a specific number of GLUT4 gold, or to the percentage of the total amount of
vp165 gold labelling which is present in those vesicles. The insert shows the equivalent analysis of the vp165 labelled vesicles. The total
number of vesicles used in the analysis was 467. The total number of GLUT4 gold particles counted was >4,200, and the total number of vp165
gold particles was >1,200.
Fig. 3. Effect of Tf/HRP ablation on vp165 levels in 3T3-L1
adipocytes. 3T3-L1 adipocytes were incubated with a Tf/HRP
conjugate for 1 hour or 3 hours at 4°C or 37°C as shown. Cells were
then treated with DAB ± H2O2 prior to subcellular fractionation. The
amount of vp165 and GLUT4 in the intracellular membrane fraction
was determined by immunoblotting, and detected using ECL or 125I-
goat anti-rabbit IgG and autoradiography, respectively. Immunoblots
were quantified by densitometry. The results of quantification are
shown in Table 2.
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Following incubation with the Tf/HRP conjugate for 3 hours
at 4°C and subsequent treatment with DAB/peroxide there was
no significant ablation of either GLUT4 or vp165 (Fig. 3) indi-
cating that ablation of these proteins at 37°C was dependent
on the recycling of the Tf/HRP conjugate through the
endosomal pathway. Together with the results of the vesicle
labelling, these results strongly suggest that vp165 is highly
colocalised with GLUT4, both in endosomes and in the
separate, post-endocytic compartment.
Cell and tissue expression of GLUT4 and vp165
Prior to immunocytochemistry the expression of vp165 and
GLUT4 was compared in heart, skeletal muscle, adipocytes,
3T3-L1 adipocytes and 3T3-L1 fibroblasts. As found in other
studies (Kandror and Pilch, 1994; Keller et al., 1995) both
proteins were strongly expressed in all three tissues and in 3T3-
L1 adipocytes (Fig. 4). However, in agreement with previous
results (Ross et al., 1996) only vp165, not GLUT4, was
expressed in 3T3-L1 fibroblasts. The results of tissue
immunoblotting suggested that heart tissue expressed high
levels of vp165 protein. To further characterise the expression
of vp165 in heart, cardiac muscle was separated into three
different regions: atrium, ventricle and papillary muscle.
Immunoblots for GLUT4 and vp165 clearly show that both
proteins are expressed in all three regions (Fig. 4). However,
GLUT4, in agreement with previous studies (Slot et al., 1997),
is more abundant in the atrium than in the ventricle, and vp165
is more abundant in the atrium and in the papillary muscle than
in the ventricle.
Intracellular localisation of vp165 in atrial
cardiomyocytes
The intracellular localisation of vp165 was compared to that of
GLUT4 in tissue sections obtained from the atrium. The atrium
was selected for these studies because we have previously
shown that atrial cardiomyocytes contain two separate
regulated GLUT4 compartments (Slot et al., 1997). One com-
partment, which contains approximately 40% of the total
GLUT4 in these cells, resembles the well-described insulin-
regulatable T-V elements found in brown adipose tissue and in
ventricular cardiomyocytes (Slot et al., 1991a,b). The
remaining GLUT4 in the atrial cardiomyocyte is targeted to the
ANF-containing secretory granules (Slot et al., 1997). This
compartment is functionally distinct from the T-V elements as
ANF, an anti-hypertensive hormone, is secreted in response to
various stimuli (De Bold, 1985; Ruskoaho, 1992) including
stretch, hypoxia, and thrombin (Klapper et al., 1996), but
serum levels are not elevated in response to insulin (Slot et al.,
1997). Thus, we felt that colocalisation experiments in this cell
type using antibodies specific for GLUT4 and vp165 would
provide a rigorous test of the similarity in targeting between
these two proteins.
By immunofluorescence, in longitudinal sections of rat
atrium, GLUT4 was concentrated in a perinuclear location
(Fig. 5A), where at higher magnification it was clearly
labelling around granules. This labelling pattern was very
similar to that of ANF (Fig. 5C). In addition GLUT4 labelling
was distributed as punctate labelling throughout the cells, pre-
senting a striated labelling pattern in areas where the cells had
been cut longitudinally (Fig. 5A). This pattern corresponds to
the sarcomeric Z-line distribution described previously for
GLUT4 (Slot et al., 1991a). In contrast, strong perinuclear
labelling was not observed for vp165 (Fig. 5B), but a
prominent dispersed punctate and striated labelling pattern, as
described above for GLUT4, was. These results suggested dif-
ferences in the distribution of these two proteins in atrial car-
diomyocytes.
Using electron microscopy, the GLUT4 subcellular distrib-
ution in atrium reported in this study was very similar to that
resolved in previous studies (Slot et al., 1997). The amount of
vp165 labelling in the sections was much lower than the
labelling for GLUT4. However the labelling was highly
Table 2. Effect of Tf/HRP ablation on intracellular 
GLUT-4 and vp165 levels
% Marker remaining in the intracellular fraction
4°C, 1 hour 37°C, 1 hour 37°C, 3 hours
H2O2 − + − + − +
GLUT-4 100 105±8 105±9 61±7 102±4 59±5
vp165 100 110±6 105±11 58±7 109±4 55±10
3T3-L1 adipocytes were treated with Tf/HRP for either 1 hour or 3 hours at
37°C or for 3 hours at 4°C, after which the DAB cytochemistry reaction was
performed in the presence (+) or absence (−) of H2O2. Cells were then
homogenised and subjected to differential centrifugation to obtain
intracellular membranes which were immunoblotted with antibodies specific
for GLUT4 and vp165. The data are expressed as a percentage of the amount
of immunoreactivity present in intracellular membranes isolated from cells
that had been incubated with Tf/HRP for 3 hours at 4°C in the absence of
H2O2. Data represent the mean ± s.e.m. of 3 experiments.
Fig. 4. Expression of GLUT4 and vp165 in heart, skeletal muscle,
adipocytes, 3T3-L1 fibroblasts and 3T3-L1 adipocytes. Total
membrane fractions were prepared from various insulin-regulatable
rat tissues and from 3T3-L1 adipocytes and fibroblasts. Samples of
each tissue (50 µg protein) were resolved by SDS-PAGE using 7.5%
polyacrylamide gels, and immunoblotted for both GLUT4 and
vp165. Immunolabelled proteins were detected using ECL. 
kDa
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specific. No specific labelling was seen in control sections
labelled using irrelevant IgG (results not shown). T-V elements
containing both GLUT4 and vp165 were present scattered
throughout the cell (Figs 6, 7), in the TGR (Fig. 8) and occa-
sionally on the trans-Golgi cisternae (Fig. 8). There was no sig-
nificant labelling of the plasma membrane because tissue was
obtained from fasted, non-stimulated animals (Fig. 6). In
contrast to recent studies in skeletal muscle (Wang et al., 1996)
there was also no significant labelling of the sarcoplasmic
reticulum. Around the myofibres the labelling was often, but
not exclusively, at the level of the Z-lines (Fig. 7). T-V elements
containing GLUT4 and vp165 were also observed close to t-
tubule membranes (Fig. 6A), and appeared to follow these spe-
cialised plasma membrane domains towards the interior of the
cell. Additionally, a large proportion of the GLUT4 labelling
was found on the membrane of the ANF granules (Figs 7, 8).
These granules were confirmed as ANF granules using an
antibody against the N terminus of the pro-ANF polypeptide
(results not shown). Most strikingly, however, in contrast to the
density of GLUT4, the ANF granule membranes were largely
devoid of vp165 labelling (Figs 7, 8).
To determine the relative distribution of vp165 and GLUT4
between the T-V elements (including the TGR) and the ANF
granules the labelling was quantified in sections of atrial car-
diomyocytes (Table 3). Over 50% of GLUT4 was found on the
ANF granule membrane, whereas there was less than 5% of
vp165 associated with this structure. In contrast 95% of vp165
was present in the T-V elements. Although vp165 was not
found in ANF granules, it was notable that vp165 positive
vesicles were occasionally observed in close proximity to the
ANF granules (Fig. 8A).
We have previously suggested that GLUT4 enters the ANF
granules as they form in the TGR (Slot et al., 1997). Therefore,
the absence of vp165 labelling in the granules could simply
reflect a difference in the absolute amounts of GLUT4 and
vp165 in the TGR. The amount of GLUT4 relative to vp165
S. Martin and others
Fig. 5. Immunofluorescence labelling of vp165, GLUT4 and ANF in
atrium. Cryosections of atrium were labelled for either GLUT4 (A),
vp165 (B), or ANF (C), and the distribution determined by
immunofluorescence. ANF labelling (C) was predominantly
perinuclear. The labelling for GLUT4 was both perinuclear (A), and
distributed throughout the cells. In regions were the atrium had been
cut in a longitudinal plane, the GLUT4 labelling appeared to be
periodic. This striated labelling pattern has been previously described
(Slot et al., 1991a, 1997), and shown to follow the sarcomeric
periodicity. Labelling for vp165 (B) was much lower than either
GLUT4 or ANF. It was distributed throughout the cells although in
regions where the atrium was cut longitudinally there was periodicity
to the labelling pattern, similar to GLUT4. There was no
concentration of vp165 labelling in the perinuclear regions of the
cells. Bars, 10 µm.
Fig. 6. Immuno-EM of GLUT4 and vp165 labelling in regions of
atrial cardiomyocytes proximal to the plasma membrane.
Cryosections of atrial cardiomyocytes are immunogold labelled for
vp165 (10 nm gold) and GLUT4 (5 nm gold). All three fields show
labelling adjacent to plasma membrane domains. In A the labelling is
close to a t-tubule, and appears to follow the path of the t-tubule
towards the interior of the cell. A large number of clathrin-coated,
predominantly unlabelled, vesicles are present around, and budding
from, the t-tubule membrane. In contrast to the t-tubule, double-
labelled T-V elements were not common in proximity to the
intercalated discs (B) between two adjacent cardiomyocytes. As both
intercalated discs and easily identifiable t-tubules were relatively rare
in atrial myocytes, the double-labelled T-V elements were
predominantly observed close to the sarcolemma (C). There was no
labelling of the plasma membrane or sarcoplasmic reticulum. Large
arrow, t-tubule; large arrowheads, intercalated disc; *, clathrin-coated
vesicles; small arrowheads, plasma membrane; m, mitochondrion;
mf, myofibres; z, Z-line; sr, sarcoplasmic reticulum. Bar, 200 nm.
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was therefore determined for the TGR and compared to
dispersed T-V elements. This analysis clearly demonstrates a
marked excess of GLUT4 relative to vp165 in the TGR (Table
4) when compared to the relative levels in the T-V elements.
However, it still does not fully explain the absence of vp165
from the ANF granules, as the ratio of GLUT4 to vp165 in the
granules (Table 4) is much higher than in the TGR.
DISCUSSION
Evidence is now accumulating to suggest that GLUT4 is
targeted to multiple intracellular compartments in adipocytes
(Verhey et al., 1995; Martin et al., 1996). Determining the
nature of these compartments will be fundamental in defining
the mechanism by which GLUT4 is translocated to the cell
surface in response to insulin. It has been shown that immuno-
precipitation of vesicles containing GLUT4 results in the co-
isolation of vp165 (Kandror and Pilch, 1994; Mastick et al.,
1994), suggesting that these two proteins have a high degree of
colocalisation. In the present study, immuno-EM on vesicles
isolated from adipocytes and cardiomyocytes confirmed that the
colocalisation between GLUT4 and vp165 is striking. Further-
more, using an endosomal ablation technique following uptake
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The gold labelling for GLUT4 and vp165 was counted in each of the
subcellular compartments shown above randomly encountered in double-
labelled sections. For each compartment the relative number of GLUT4 gold
particles per vp165 gold particle was calculated. Results shown are the
average number of GLUT4 per vp165. Three separate sections were
quantified. A total of >500 gold particles were counted for GLUT4 in each
compartment. Results are expressed as mean ± s.e.m. except for ANF
granules. Due to the very low amount of vp165 in the ANF granules relative
to the GLUT4 labelling this ratio was not averaged, and the range is shown.
Fig. 7. Immuno-EM of GLUT4 and vp165 labelling in dispersed T-V elements of the atrial cardiomyocyte. Cryosections were double-labelled
for vp165 (10 nm gold) and GLUT4 (5 nm gold). Labelled T-V elements were distributed throughout the atrial cardiomyocyte, however, they
were often, but not exclusively located in parallel to the Z-line of the myofibre. ANF granules (ag) labelled for GLUT4 were also distributed
throughout the cell, although they were most concentrated in the perinuclear, Golgi-enriched areas (see Fig. 8). These secretory granules did not
label for vp165, although occasionally vp165 labelled T-V elements were in very close proximity to them. Bar, 200 nm.




T-V elements/TGR 41.6±5.0 94.6±1.5
ANF granules 58.2±5.0 3.8±0.3
Plasma membrane 0.2±0.1 1.6±1.0
Gold particles were counted randomly in longitudinally cut sections of
basal atrial cardiomyocytes. Over these regions the cells were transversed at
an angle of approximately 90° to the myofibres. Three sections from two
different atria were counted and averaged. In the same area random points
were projected on the sections. These points were assigned to myocyte
structures as if they were gold particles. Approximately 90% of the random
points were found over unlabelled structures. Over 95% of the GLUT4
labelling was found on the structures included in the table, together with 75%
of the vp165 labelling. The remaining vp165 labelling was predominantly
over mitochondria and myofibres and was considered non-specific. The
Golgi/TGR and T-V elements were combined for comparison with the ANF
granules. For GLUT4 between 300-600 gold particles, and for vp165 between
40-60 gold particles, were quantified per section, respectively. Results are
expressed as the mean ± s.e.m.
Fig. 8. Immuno-EM of GLUT4 and vp165 in TGR and ANF
granules. Immunogold labelling of vp165 (10 nm gold) and GLUT4
(5 nm gold) in the Golgi region of atrial cardiomyocytes. Adjacent to
the nuclei of the atrial cardiomyocytes are regions densely packed
with ANF granules and enriched in Golgi (g). In these regions
GLUT4 labelling is present on the ANF granules, in the TGR (tgr)
and in trans-Golgi cisternae (A,B), while the vp165 labelling is
predominantly present in the TGR (A,B). There is no vp165 on the
ANF granules. In the region of the Golgi, T-V elements labelled for
vp165 were observed in very close proximity to the ANF granules
(A). However, these T-V elements did not appear to be coated, and
were not close to the patches of clathrin coat (small arrows) often
seen on the ANF granule. Bar, 100 nm.
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of a Tf/HRP conjugate we show that vp165 is distributed among
distinct intracellular compartments in a similar way to GLUT4
in 3T3-L1 adipocytes. In fact, of all markers that we have
examined thus far using these techniques, vp165 shows the
highest degree of colocalisation with GLUT4. We also demon-
strate that vp165 and GLUT4 colocalise almost completely
within a tubulo-vesicular compartment in atrial cardiomyocytes
similar to that previously identified as housing GLUT4 in brown
adipose tissue and ventricular cardio-myocytes (Slot et al.,
1991a,b). Thus, overall these studies suggest that these two
proteins are sorted in a highly analogous manner when
expressed together in both muscle and adipose tissue. This may
be due to similar targeting properties and may also be facili-
tated by a close association between the two proteins. Work is
currently under way to determine if this is the case. It is inter-
esting to note however, that vp165 has a broader tissue distri-
bution than GLUT4, and is expressed in all major tissues, except
in liver, where the amount is low (Keller et al., 1995). The
function of vp165 in any tissue is not yet known. However, pre-
liminary studies have indicated that in other cell types, in which
glucose transport is not acutely regulated by insulin, vp165 has
a different localisation to that described in the present study (J.
Slot, unpublished observations). 
Despite the high degree of overlap between GLUT4 and
vp165 we present evidence that the intracellular distribution of
these proteins is not identical. In the atrial cardiomyocyte, in
contrast to GLUT4, vp165 was not found in the ANF secretory
granules. This is unlikely to be due to a low detection or
labelling density for vp165, as the antibodies clearly labelled
vp165 when it was present in T-V elements. We have previ-
ously suggested that GLUT4 enters this secretory compartment
at the level of the TGR, as the secretory granule is budding
from the Golgi (Slot et al., 1997). As it is known that trans-
Golgi reticular GLUT4 is largely derived from a recycling
pathway and not from the biosynthetic route (Slot et al., 1997)
this result suggests differences in the subcellular trafficking
pathways or retention times between GLUT4 and vp165 in the
TGR. 
The presence of vp165 in the TGR was morphologically
demonstrated in immunolabelled cryosections (Fig. 8), and
indirectly confirmed by the colocalisation vp165 with the γ-
adaptin subunit of the TGR adaptor complex, AP-1, in vesicles
from adipocytes (S. Martin and D. E. James, unpublished data).
However, the absence of vp165 from the granules could partly
reflect the fact that the TGR contains relatively little vp165
compared to the T-V elements (Table 4). Another intriguing
possibility is suggested by the presence of AP-1 positive
patches of clathrin coat on the ANF granules (Slot et al., 1997)
which could provide the basis for an exit pathway for
membrane proteins. However, there is little structural
homology between vp165 and GLUT4 and so it is highly likely
that they may exhibit differences in targeting in different cell
types. Numerous studies have been performed attempting to
dissect linear targeting motifs in GLUT4, that encode for its
intracellular sequestration (Piper et al., 1993: Corvera et al.,
1994; Verhey and Birnbaum, 1994; Marsh et al., 1995; Verhey
et al., 1995). Now with the identification of another protein that
appears to be targeted very similarly to GLUT4 it will be
possible to compare and contrast these motifs between the two
proteins. It has been proposed that GLUT4 contains at least
two separate targeting domains. One is in the C-terminal cyto-
plasmic tail and involves a dileucine motif similar to that
described in numerous other recycling proteins (Shin et al.,
1991; Johnson and Kornfeld, 1992; Chen et al., 1993; Pieters
et al., 1993; Aiken et al., 1994; Bremnes et al., 1994; Pond et
al., 1995; Dietrich et al., 1996; Dittrich et al., 1996). In
addition, it has been suggested that there may be a second,
separate targeting motif in this tail (Verhey et al., 1995).
Although vp165 has only a single cytoplasmic domain it
contains multiple dileucine motifs and a highly acidic region
(Keller et al., 1995) similar to that found at the extreme C
terminus of GLUT4 (James et al., 1989). Hence, it will be of
interest to determine if these motifs subserve a common
function in both proteins. The N-terminal cytoplasmic tail of
GLUT4 has also been suggested to play an important role in
the molecular targeting of the protein (Piper et al., 1992, 1993;
Marsh et al., 1995). This region contains a FQQI motif similar
to tyrosine-based motifs found in other recycling proteins
(reviewed by Trowbridge et al., 1993). It is of particular interest
that there is a high degree of homology between this region of
GLUT4 and the N-terminal of GAD65, the region suggested
to encode for targeting information that allows the latter protein
to associate with secretory granules (Shi et al., 1994; Solimena
et al., 1994). Considering that this domain is not conserved in
vp165, this may explain why GLUT4 but not vp165 is targeted
to secretory granules in atrial cardiomyocytes.
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